注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
C4 Therapeutics Inc是一家生物製藥公司。該公司致力於利用人體對蛋白質水平的自然調節來開發備選藥物,以針對和破壞引起疾病的蛋白質,從而治療癌症、神經退行性疾病和其他疾病。該公司提供的技術平台,即面向目標的蛋白質降解優化劑(TORPEDO),合成一類新型的小分子蛋白質降解物,旨在降解引起疾病的蛋白質,其中包括先前被認為不可食用的目標。該公司的主要備選產品CFT7455是針對多發性骨髓瘤(MM)、外周T細胞淋巴瘤(PTCL)和套細胞淋巴瘤(MCL)的IKZF1/3的口服生物可利用降解劑。該公司也正在開發CFT8634,這是一種被稱為溴結構域的口服生物可利用的蛋白質靶標降解物,含9(BRD9),用於治療滑膜肉瘤和SMARCB1缺失的實體瘤。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Andrew J. Hirsch | 51 | 2020 | CEO, President & Director |
Kenneth C. Anderson | 71 | 2015 | Co-Founder, Independent Director & Member of Scientific Advisory Board |
Donna Roy Grogan | 66 | 2022 | Independent Director |
Laura Bessen | - | 2022 | Independent Director |
Bruce L. Downey | 76 | 2015 | Chairman & Lead Independent Director |
Nathanael S. Gray | - | 2016 | Co-Founder & Member of Scientific Advisory Board |
Christopher J. Kirk | 50 | 2016 | Member of Scientific Advisory Board |
Glenn Russell Dubin | 66 | 2021 | Independent Director |
Ross L. Levine | 51 | 2017 | Member of Scientific Advisory Board |
Randi Isaacs | 67 | - | Member of Clinical Advisory Board |
Scott A. Armstrong | - | 2017 | Member of Scientific Advisory Board |
Christopher J. Bowden | 62 | - | Member of Clinical Advisory Board |
Hagop Youssoufian | 66 | 2023 | Member of Clinical Advisory Board |
Malcolm S. Salter | 83 | 2015 | Independent Director |
Utpal Koppikar | 52 | 2022 | Independent Director |
Beni B. Wolf | - | - | Member of Clinical Advisory Board |
Ryan B. Corcoran | - | 2019 | Member of Scientific Advisory Board |
Owen P. Hughes | 48 | 2023 | Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核